TABLE 6.
Clonea | Type | Antigen specificity | HIV gag RNA (mol/μg of RNA)b
|
||
---|---|---|---|---|---|
Day 2 | Day 5 | Day 10 | |||
H1.15 | TH1 | TTx | 10,600 | 25,300 | 41,000 |
H1.12 | TH1 | TTx | 8,400 | 20,100 | 36,800 |
H1.18 | TH1 | TTx | 9,100 | 23,700 | 39,200 |
H2.25 | TH2 | TTx | 11,700 | 31,100 | 52,600 |
H2.29 | TH2 | TTx | 2,000 | 10,800 | 19,100 |
H2.33 | TH2 | TTx | 7,300 | 21,400 | 37,700 |
Derivation, antigen activation, and HIVIIIB infection of T-cell clones were performed as described in Materials and Methods.
Construction and use of an RNA standard and RT-PCR analysis are described in Materials and Methods. For quantitation of number of HIV gag mRNA molecules, the gel was scanned on a PhosphorImager (Molecular Dynamics), using ImageQuant and Microsoft Excel programs, in comparison to a standard curve in a linear range on each gel. Viral samples were diluted to fall within the standard curve.